| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.8 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.8 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |